Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lipase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel enzymatic process ensures 95-100% purity. Reduces oxidation risks and offers scalable solutions for nutritional ingredients manufacturing.
Patent CN101104861B reveals a novel Yarrowia lipolytica lipase method for S-ibuprofen. Discover cost-effective, high-selectivity biocatalysis for pharmaceutical manufacturing.
Patent CN102174422B reveals high-activity lipase for chiral resolution. Offers solvent stability and cost reduction in biocatalysis manufacturing for pharma intermediates.
Patent CN101475968B reveals lipase-catalyzed synthesis. High purity, mild conditions. Ideal for pharma and nutrition supply chains seeking green alternatives.
Patent CN101914595A reveals enzymatic route for ferulic acid sugar esters offering green manufacturing advantages and supply chain stability for global pharmaceutical intermediates procurement.
Patent CN1425019A discloses a novel enzymatic route for vitamin D precursors, offering cost reduction in pharmaceutical intermediates manufacturing through scalable crystallization.
Patent CN106755254B details a mild enzymatic route for lipoic acid sterol ester, offering high purity and yield for food and pharma applications.
Patent CN102517353A details a green enzymatic route for heterocyclic ketones. Offers high ee values and mild conditions for pharma intermediates.
Patent CN109929822A reveals enhanced lipase mutants for resolving chiral esters. This breakthrough offers significant cost reduction and supply chain reliability for agrochemical intermediate manufacturing.
Patent CN109182298B details engineered lipase mutants for high-efficiency resolution of moxifloxacin intermediates, offering significant cost reduction and supply chain reliability.
Discover the environmentally friendly synthesis of chiral 2,3-alkenols using lipase catalysis. A breakthrough in pharmaceutical intermediate manufacturing offering high purity and cost efficiency.
Patent CN105420285B reveals a scalable enzymatic method for producing optically active heptadecene compounds, offering significant cost reduction and supply chain reliability for agrochemical manufacturers.
Patent CN110218758A reveals enzymatic lutein ester synthesis offering high purity and mild conditions for reliable pharmaceutical intermediate supply chain optimization.
Patent CN1220702A details a novel enzymatic process for producing high-purity optically active amines, offering significant cost reduction and supply chain reliability for agrochemical and pharmaceutical intermediates.
Patent CN113151375B reveals enzymatic synthesis improving yield and safety. Reliable supplier for cost reduction in sweetener manufacturing and supply chain stability.
Novel lipase mutant enhances Pregabalin intermediate synthesis efficiency and purity. Cost-effective biocatalytic solution for pharmaceutical manufacturing supply chains.
Patent CN110438194B details a novel lipase F11 for resolving DL-tropine methyl ester with >99% ee. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN103667397B details enzymatic synthesis for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN105461606B details enzymatic hydrolysis for Ledipasvir intermediates. Achieve >99% de value and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101045936B details a novel enzymatic resolution process using succinic anhydride, offering significant cost reduction and simplified purification for pharmaceutical intermediates.